Release Date: 26/02/20 08:12 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 529.37KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%